An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu

Summary

The purpose of the study is to assess the short term efficacy of the Theraflu Aktiv powder for oral solution in the Russian population as compared to an untreated group to support the indication of "Short term relief of the symptoms of colds, chills and influenza, including mild to moderate pain, fever and nasal congestion".

Timeline

Start

2017-02-01

Primary completion

2017-04-01

Completion

2017-04-01

Outcome

Outcome not reported

Stopped: “The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's decision.”

Drugs

Indications